Mikatan Plus Tablet 80/12.5 mg

Adult dose

For patients whose blood pressure is not adequately controlled with telmisartan alone, it is taken once daily with a beverage regardless of meals. Before switching to this fixed-dose combination drug, it is recommended to adjust the dose of each component individually based on the patient. When clinically appropriate, it may be directly switched from monotherapy to this medication. - Telmisartan/Hydrochlorothiazide combination 40/

Child dose

This medication is not administered to children under 18 years of age as its safety and efficacy have not been established.

This medication can cause serious harm to the fetus, especially during the second and third trimesters of pregnancy, so if pregnancy is confirmed, it must be stopped immediately. This drug should not be used by those who are allergic to the ingredients or additives, as well as pregnant or breastfeeding women, those with issues related to bile or the biliary tract, and patients with severe liver or kidney disease. Elderly patients or those with high potassium levels, poor liver function, heart valve disease, or cerebrovascular disease should use this drug with caution. This medication can cause photosensitivity reactions on the skin, so it is important to minimize sun exposure and consult a doctor immediately if skin abnormalities occur. During use, symptoms such as dizziness, low blood pressure, and electrolyte imbalances (potassium, sodium, magnesium, etc.) may arise, so regular blood tests are recommended. This drug may interact with other antihypertensives, diuretics, lithium, potassium supplements, etc., so it is essential to consult with a physician or pharmacist before co-administration. Driving or operating machinery may cause drowsiness or dizziness, so caution is advised. In case of overdose, symptoms such as low blood pressure, electrolyte imbalances, and dehydration may occur, requiring immediate medical attention. It is not recommended for use in children under 18 years of age as safety and efficacy have not been established.

Serious side effects

Urticaria, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, peeling skin, pain in mucous membranes (mouth/eyes), shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, jaundice (yellowing of skin or eyes), severe lethargy, sudden and severe headaches, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis.

Mild side effects

Bronchitis, pharyngitis, sinusitis, hypokalemia, hyperuricemia, hyponatremia, anxiety, depression, insomnia, sleep disturbances, dizziness, visual disturbances, blurred vision, vertigo, tachycardia, arrhythmia, hypotension, orthostatic hypotension, difficulty breathing, pneumonia, pulmonary edema, diarrhea, dry mouth, bloating, abdominal pain, constipation, indigestion, vomiting, liver function abnormalities/liver impairment, erythema, pruritus, rash, hyperhidrosis, urticaria, back pain.

This drug should be stored in a sealed container to prevent exposure to air or moisture, with a safe storage temperature range between 1 degree and 30 degrees Celsius. This storage condition will help maintain the drug's effectiveness and prevent deterioration.

Appearance

An oval-shaped tablet consisting of a white and pink layer, with the white layer possibly having pink specks.

Package unit

30 tablets (10 tablets/PTPX3)